Institutional Ownership Rocket Pharmaceuticals, Inc. (RCKT)
This table provides information about the institutional ownership of Rocket Pharmaceuticals, Inc. (RCKT). We have compiled data on the 195 institutions that hold shares in the stock, with a total of 96.5 Million shares, which have been reported (via 13F filing form) to have a value of $294 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Rtw Investments, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
17,687,772
shares
|
$53.9 Million
0.77% of portfolio
|
Q4 2022
Added 11.93%
|
|
|
Lee Ainslie
Maverick Capital LTD | Dallas, Tx
|
Nov 14, 2025 Q3 2025 |
8,468,344
shares
|
$25.8 Million
0.41% of portfolio
|
Q3 2025
Added 1.25%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
6,892,204
shares
|
$21 Million
0.0% of portfolio
|
Q3 2025
Added 12.57%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
6,192,627
shares
|
$18.9 Million
0.0% of portfolio
|
Q2 2024
Added 4.43%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
Nov 14, 2025 Q3 2025 |
3,903,381
shares
|
$11.9 Million
2.3% of portfolio
|
Q3 2025
Added 0.01%
|
|
|
Suvretta Capital Management, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
3,843,333
shares
|
$11.7 Million
0.38% of portfolio
|
Q3 2025
Reduced 7.24%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
3,647,039
shares
|
$11.1 Million
0.0% of portfolio
|
Q3 2025
Added 15.08%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2025 Q3 2025 |
3,570,391
shares
|
$10.9 Million
0.01% of portfolio
|
Q3 2025
Added 52.01%
|
|
|
Monaco Asset Management Sam
|
Nov 10, 2025 Q3 2025 |
2,892,261
shares
|
$8.82 Million
0.58% of portfolio
|
Q3 2025
Added 538.8%
|
|
|
Newtyn Management, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
2,502,863
shares
|
$7.63 Million
1.36% of portfolio
|
Q3 2025
Added 25.14%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Nov 14, 2025 Q3 2025 |
2,189,750
shares
|
$6.68 Million
0.0% of portfolio
|
Q3 2025
Added 120.56%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 26, 2025 Q3 2025 |
2,097,033
shares
|
$6.4 Million
0.0% of portfolio
|
Q3 2025
Added 243.73%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
1,914,554
shares
|
$5.84 Million
0.0% of portfolio
|
Q3 2025
Reduced 5.73%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Nov 14, 2025 Q3 2025 |
1,795,751
shares
|
$5.48 Million
0.01% of portfolio
|
Q3 2025
Added 20.5%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
1,745,310
shares
|
$5.32 Million
0.0% of portfolio
|
Q3 2025
Reduced 10.21%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2025 Q3 2025 |
1,670,927
shares
|
$5.1 Million
0.0% of portfolio
|
Q3 2025
Added 970.76%
|
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
1,609,682
shares
|
$4.91 Million
0.01% of portfolio
|
Q3 2025
Reduced 6.7%
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
Nov 14, 2025 Q3 2025 |
1,313,737
shares
|
$4.01 Million
0.01% of portfolio
|
Q3 2025
Added 896.72%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
1,271,093
shares
|
$3.88 Million
0.0% of portfolio
|
Q3 2025
Reduced 19.32%
|
|
|
Prosight Management, LP
Dallas, TX |
Nov 14, 2025 Q3 2025 |
1,267,965
shares
|
$3.87 Million
1.09% of portfolio
|
Q3 2025
Reduced 19.78%
|
|
|
Putnam Investments LLC
Boston, MA |
Feb 14, 2024 Q4 2023 |
1,069,715
shares
|
$3.26 Million
0.04% of portfolio
|
Q4 2023
Added 7.05%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
1,061,295
shares
|
$3.24 Million
0.0% of portfolio
|
Q3 2025
Reduced 3.5%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2025 Q3 2025 |
1,014,358
shares
|
$3.09 Million
0.0% of portfolio
|
Q3 2025
Reduced 34.48%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
Nov 14, 2025 Q3 2025 |
873,247
shares
|
$2.66 Million
0.0% of portfolio
|
Q3 2025
Added 12.29%
|
|
|
Tang Capital Management LLC
San Diego, CA |
Nov 14, 2025 Q3 2025 |
850,000
shares
|
$2.59 Million
0.13% of portfolio
|
Q1 2025
Added 13.33%
|
|